Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepivacaine vs Bupivacaine for Early Ambulation in Hip Arthroplasty
NCT03948386Phase 4Completed
- Sponsor
- Thomas Jefferson University
- Start
- May 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of mepivacaine in osteoarthritis (OA) (3 arms), sponsored by Thomas Jefferson University. Primary endpoint: Percentage Ambulating Early After Spinal Anesthesia at 3.5 hours. Started May 2019; status: completed.
02
Drugs
mepivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03948386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948386.